TCG Crossover GP I, LLC - 19 Nov 2025 SCHEDULE 13G Report for Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share (TRDA)

Filing Manager
TCG Crossover GP I, LLC
Reporting Manager
TCG Crossover GP I, LLC
Security
Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
TRDA
Shares outstanding
38,346,880 shares
Disclosed Ownership
1,917,344 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
25 Nov 2025, 16:29:15 UTC
Date of event
19 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP I, LLC 5% 1,917,344 0 1,917,344 /s/ Craig Skaling Authorized Signatory
TCG Crossover Fund I, L.P. 5% 1,917,344 0 1,917,344 /s/ Craig Skaling Authorized Signatory
Chen Yu 5% 1,917,344 0 1,917,344 /s/ Craig Skaling By POA as Attorney-in-Fact